Streetbeat News

Products Services

EVLV

The Department of Investigation is probing NYC Mayor Adams' administration regarding the installation of Evolv's weapons scanners in the MTA subway system. This investigation could impact Evolv Technologies' stock.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 3:07 pm

NIO

TSLA

XPEV

The European Union is set to impose tariffs of up to 45% on Chinese-made electric vehicles for the next five years, aiming to protect European carmakers from rising competition. This decision comes despite concerns about potential retaliation from China.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:56 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides a detailed analysis of SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, highlighting key support and resistance levels for each. The memo emphasizes the importance of monitoring these stocks for potential breakouts or reversals, especially with upcoming economic indicators and a Fed official's speech that could impact market volatility.

Portfolio Pulse from RIPS

October 04, 2024 | 2:52 pm

SNY

Sanofi has sold the global rights to its rare autoimmune drug Enjaymo to Recordati for $825 million upfront, with potential milestone payments of $250 million. Enjaymo, approved by the FDA in 2022, is expected to see significant revenue growth. The deal is set to close by the end of 2024.

Portfolio Pulse from Vandana Singh

October 04, 2024 | 2:42 pm

TMUS

BakedBot AI, founded by Martez Knox, is revolutionizing the cannabis industry with AI-driven bots that enhance customer experiences and streamline dispensary operations. The company addresses marketing challenges by using AI to improve customer engagement and optimize business processes. BakedBot AI's tools help dispensaries personalize customer interactions, optimize pricing, and manage inventory effectively.

Portfolio Pulse from Nicolás Jose Rodriguez

October 04, 2024 | 2:27 pm

LLY

NVO

NHS England is considering a phased rollout of Eli Lilly's weight-loss drug Mounjaro (tirzepatide) to improve patient outcomes. The drug has shown significant weight loss results in trials. The plan includes integrating the drug into community services and digital platforms, targeting up to 240,000 people over three years.

Portfolio Pulse from Vandana Singh

October 04, 2024 | 2:19 pm

IREN

Iris Energy Limited (NASDAQ:IREN) reported a 42% increase in revenue for September, mining 347 Bitcoin and reducing electricity costs by 21%. The company expanded its GPU fleet and aims to increase capacity to 31 EH/s by Q4 2024. Analysts maintain positive ratings with a price target of $16.5.

Portfolio Pulse from Erica Kollmann

October 04, 2024 | 2:16 pm

TINT

XLB

DuPont de Nemours, Inc. has completed a major expansion of its photoresist manufacturing capacity in Japan, nearly doubling production to meet global demand. This move is part of DuPont's growth strategy in lithography offerings. The company's stock has gained over 18% in the past year, and investors can gain exposure through ETFs like ProShares Smart Materials ETF and Materials Select Sector SPDR.

Portfolio Pulse from Nabaparna Bhattacharya

October 04, 2024 | 2:06 pm

CAPR

Capricor Therapeutics shares rose following the announcement that the company will present long-term data from its HOPE-2 open-label extension study at the 2024 World Muscle Society Congress.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 2:06 pm

LEVI

Levi Strauss & Co (NYSE:LEVI) reported a mixed quarterly performance with a 5% sales growth but flat overall revenue. The company is considering selling its Dockers brand due to declining sales. Levi's direct selling strategy, aided by lower cotton costs, improved its gross margin. Despite missing revenue estimates, Levi reaffirmed its full-year earnings guidance.

Portfolio Pulse from Upwallstreet

October 04, 2024 | 2:04 pm